October 17, 2024There is a lot of hype around in-vitro tissue engineering, because ‘growing an organ in a lab’ appears futuristic. To…
October 17, 2024Osteopore, an Australian and Singapore based leader in regenerative implants on a commercial scale, is developing technology that enables widespread…
October 17, 2024The science of tissue engineering and regenerative medicine aims to provide surgeons with a sustainable solution to patients undergoing reconstructive…
October 17, 2024At Osteopore, we are global leaders in the design and manufacture of regenerative biomimetic scaffolds. Our bioresorbable implant is the…
October 17, 2024Three dimensional or “3D printing” is an additive manufacturing process that has been around for a while now – but…
October 17, 2024Osteopore Limited (ASX: OSX), a global leader in the manufacture of innovative regenerative implants that empower natural tissue regeneration, is…
October 17, 2024Osteopore Limited (ASX:OSX), a revenue-generating manufacturer of regenerative implants that empower natural tissue regeneration, is pleased to announce that it…
